Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.1.1.u2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Apr. 30, 2024
Apr. 30, 2023
Income Statement [Abstract]        
Revenues $ 8,022 $ 7,485 $ 24,381 $ 22,102
Operating costs and expenses:        
Cost of revenues 4,289 4,476 12,969 13,681
Research and development 605 884 2,035 2,708
Selling, general and administrative 4,479 6,212 16,550 17,078
Legal and related expense, net 692 4,265 2,527 6,160
Total operating costs and expenses 10,065 15,837 34,081 39,627
Operating loss (2,043) (8,352) (9,700) (17,525)
Other income (expense):        
Interest, net 726 (36) 2,595 99
Change in fair value of convertible debentures (384) (1,095)  
Other 94 144 373 262
Foreign exchange (loss) gain (524) 347 (842) 1,022
Total other income (expense) (88) 455 1,031 1,383
Loss before income taxes (2,131) (7,897) (8,669) (16,142)
Income taxes    
Net loss from continuing operations (2,131) (7,897) (8,669) (16,142)
Net loss from discontinued operations (889) (7,290) (4,028) (21,000)
Net loss $ (3,020) $ (15,187) $ (12,697) $ (37,142)
Net loss per common share – basic and diluted:        
Continuing operations (in Dollars per share) $ (0.04) $ (0.16) $ (0.17) $ (0.33)
Discontinued operations (in Dollars per share) (0.02) (0.15) (0.08) (0.43)
Total net loss per basic and diluted common share (in Dollars per share) $ (0.06) $ (0.31) $ (0.25) $ (0.76)
Weighted average common shares outstanding:        
Basic (in Shares) 51,214 49,384 50,629 48,944